Auto-generated every Monday. Includes volume, accuracy, flag rates, SLA compliance, and top reviewers for the prior week.
Week of March 16, 2026
Total Cases: 67 | Completed: 52 | Flagged: 6
Avg Review Time: 10.4 min | SLA Met: 89%
Top Reviewer: Maria Chen (51 cases, 2% flag rate)
Full Case History Export
Export all cases with reviewer, timestamps, attestation status, financial fields, and adjustment codes for billing or external audit submission.
Payer Turnaround Time
Payer
Cases
Avg. Review Time
Longest
UnitedHealthcare
48
10 min
24 min
Aetna Better Health
30
13 min
31 min
Humana
35
9 min
18 min
BCBS Illinois
27
11 min
22 min
Wellcare
22
12 min
28 min
Reviewer Accounts
Name
Email
Role
Status
Last Active
Actions
Jane Doe
jane@medmonk.com
Reviewer
Active
Today 10:14 AM
Alex Rivera
alex@medmonk.com
Reviewer
Active
Today 9:35 AM
Sam Lee
sam@medmonk.com
Reviewer
Active
Yesterday 4:50 PM
Maria Chen
maria@medmonk.com
Reviewer
Active
Today 8:30 AM
Add New Reviewer
Full Name
Email
Role
Password Reset
Reviewer Email
Commercial Copay Cases
18
This month
Total Reimbursed
$9,400
Checks issued to facilities
Checks Pending
3
Awaiting issuance
Other Programs
13
PAP / Free Trial / Compassionate
Check Reimbursement Tracker — Commercial Copay
Case ID
Patient
Facility
Program
Check Amount
Check #
Issue Date
Status
Action
C-2026-0084
Margaret T. Collins
Northshore Specialty Pharmacy
Octagam Copay
$500.00
OCT-2026-00847
Mar 18, 2026
Issued
C-2026-0083
Patricia L. Moore
Northshore Specialty Pharmacy
Octagam Copay
$500.00
OCT-2026-00831
Mar 15, 2026
Received
C-2026-0092
Daniel M. Reyes
Northshore Specialty Pharmacy
Wilate Copay
$750.00
—
—
Pending
C-2026-0081
Maria E. Gonzalez
Midwest Specialty Rx
Octagam Copay
$500.00
OCT-2026-00819
Mar 12, 2026
Received
Other Program Tracking — PAP / Free Trial / Compassionate Care
These programs are managed externally. This log is for internal reference only — enrollment, fulfillment, and reimbursement are handled directly by the manufacturer or program administrator.
Case ID
Patient
Program Type
Managed By
Enrollment Status
Notes
C-2026-0086
Linda K. Watts
Free Trial
Octapharma Direct
Enrolled
30-day free trial initiated
C-2026-0087
George T. Simmons
Compassionate Care
Octapharma Direct
Pending
Application submitted, awaiting approval
C-2026-0079
Dorothy R. Kim
PAP
Octapharma Direct
Active
Income verified, monthly supply approved
Program Breakdown
Program
Cases
Total Value
Commercial Copay Assistance
18
$9,400.00
PAP
5
Manufacturer managed
Free Trial
4
Manufacturer managed
Compassionate Care
4
Manufacturer managed
Facility Reimbursement Summary
Facility
Checks Issued
Total Paid
Pending
Northshore Specialty Pharmacy
8
$4,000.00
$750.00
Midwest Specialty Rx
5
$2,500.00
$0.00
Central Infusion Services
4
$2,000.00
$500.00
Other
2
$900.00
$0.00
EOB
HCFA 1500
ERA 835
Ins. Card
EOB Document
Uploaded by provider — click fields in extracted panel to highlight source location
EXPLANATION OF BENEFITS Payer: UnitedHealthcare (Medicare Advantage) Contract ID: H0169 | BIN: 610097 | PCN: 9999 Member ID: 1AB2CD3EF45 Member: MARGARET T COLLINS DOB: 03/12/1947 | Age: 78 Group #: 80652 | Seq: 253
Provider: NORTHSHORE SPECIALTY PHARMACY NPI: 1234567890 Date of Service: 03/10/2026
Rx #: 9201547 | NDC: 67467-0843-20 Drug: Octagam 10% 20g/200mL Billed: $8,400.00 Allowed: $8,232.00 Sequestration (Adj 253): -$164.64 Plan Paid: $7,567.36 Member Copay: $500.00 Member Responsibility: $500.00
Medicare Advantage plan — Sequestration (Adj. 253) applies
AI Observations
Medicare/Medicare Advantage Patient — Age 78, Member ID pattern 1AB2CD3EF45 confirms Medicare Advantage. Sequestration Adj. Code 253 present on EOB. RxPCN: 9999 matches UHC Medicare Part D (BIN 610097). M3P/MPPP BIN confirmed.
️
Sequestration Applied: $164.64 reduction (Adj 253) per Medicare Advantage rules — confirm plan paid amount reflects 2% sequestration reduction from $8,232.00 → $7,567.36.
UHC Contract ID H0169 found in Part D reference. PCN 9999, BIN 610097 — consistent with M3P MPPP enrollment. Verify M3P payment spread if applicable.
⚡
Quick Confirm Available
AI extracted all fields with 96%+ confidence and no flags. Review the summary below and confirm in one tap.
AI-Assisted Intake — Case C-2026-0084
Review extracted fields, confirm accuracy, then submit. Highlighted fields need attention.
Medicare AdvantageOverall: 94% Conf.
⚠
2 Fields Need Your Attention
Fields highlighted in yellow require manual verification before this case can be completed:
Sequestration (Adj 253) — -$24.30: Confirm this equals exactly 2% of the allowed amount ($1,214.80 × 2% = $24.30)
Plan Paid — $890.50: Verify this reflects the billed amount minus sequestration and member copay ($1,214.80 − $24.30 − $300.00 = $890.50)
✓ Once verified, update the intake form fields and check the attestation box below before submitting.
Government-funded plans (Medicare, Medicaid, Tricare) are not eligible for manufacturer copay assistance programs per federal anti-kickback regulations.
Copay Assistance & Patient Access
Commercial Plan
Program Benefit Limit
Annual Maximum: $25,000.00
Program Paid
$3,200.00
This Claim
$500.00
Remaining
$21,800.00
14% of annual limit used ($3,500.00 of $25,000.00 after this claim)
Copay Assistance Program
Program / Enrollment ID
Amount Requested
Copay Case ID
Dispensing Provider / Facility
Facility Name
Phone Number
Facility Address
Prescriber / Referral
Referring Physician / Prescriber Name
Clinical Notes / Additional Information
Check Reimbursement — Facility Payment
Octapharma USA, Inc.
1020 First Avenue, King of Prussia, PA 19406
Check No.
OCT-2026-00847
Date
March 18, 2026
Amount
$500.00
Pay to the order of
Northshore Specialty Pharmacy
1200 N. Milwaukee Ave, Glenview, IL 60025
Memo: Copay reimbursement — Case C-2026-0084 | Patient: Margaret T. Collins | Octagam 10% | DOS: 03/10/2026
Authorized Signature: ___________________________
Case ID
C-2026-0084
Patient
Margaret T. Collins
Facility
Northshore Specialty Pharmacy
Program
Octagam Copay Assistance
Check Amount
$500.00
Check Number
OCT-2026-00847
Issue Date
March 18, 2026
Status
Issued
Review Checklist — Complete Before Attesting
Flag for Further Review
Please confirm the reason this case needs further review. A note is required.